Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. Lopez J, Mommert M, Mouton W, Pizzorno A, et al. J Exp Med 2021;218.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lopez J, Mommert M, Mouton W, Pizzorno A, et al. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med 2021;218.
PMID: 34357402